ILMN Key Statistics, Chart & Performance
The current stock price of ILMN is 141.65 USD. In the past month the price increased by 9.33%. In the past year, price increased by 3.64%.
ILMN Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ILMN. When comparing the yearly performance of all stocks, ILMN is one of the better performing stocks in the market, outperforming 85.42% of all stocks.
ILMN Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ILMN. While ILMN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
ILMN Financial Highlights
Over the last trailing twelve months ILMN reported a non-GAAP Earnings per Share(EPS) of 4.36. The EPS increased by 152.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.39% | ||
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| Debt/Equity | 0.42 |
ILMN Forecast & Estimates
27 analysts have analysed ILMN and the average price target is 132.25 USD. This implies a price decrease of -6.64% is expected in the next year compared to the current price of 141.65.
For the next year, analysts expect an EPS growth of 96.03% and a revenue growth -0.86% for ILMN
ILMN Ownership
ILMN Latest News, Press Relases and Analysis
ILMN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 27.62 | 232.46B | ||
| DHR | DANAHER CORP | 30.61 | 166.69B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 188.8 | 57.37B | ||
| IQV | IQVIA HOLDINGS INC | 20.44 | 40.48B | ||
| A | AGILENT TECHNOLOGIES INC | 25.03 | 39.59B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 34.91 | 29.84B | ||
| WAT | WATERS CORP | 30.5 | 23.06B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 36.75 | 18.69B | ||
| MEDP | MEDPACE HOLDINGS INC | 42.72 | 17.21B | ||
| RVTY | REVVITY INC | 23.49 | 12.76B | ||
| TEM | TEMPUS AI INC | N/A | 12.51B | ||
| CRL | CHARLES RIVER LABORATORIES | 20.82 | 10.81B |
Related stock screener links
About ILMN
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
Company Info
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA 92122 US
CEO: Francis A. deSouza
Employees: 8970
Phone: 18582024500
ILLUMINA INC / ILMN FAQ
Can you describe the business of ILLUMINA INC?
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,970 full-time employees. The company went IPO on 2000-06-28. Its products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, referred to as sequencing by synthesis biochemistry. Its BeadArray technology combines microscopic beads and a substrate in a manufacturing process to produce arrays that can perform many assays simultaneously. Its sequencing applications include whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which can sequence exomes, specific genes, RNA or other genomic regions of interest. Its customers include genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and others.
Can you provide the latest stock price for ILLUMINA INC?
The current stock price of ILMN is 141.65 USD. The price decreased by -2.51% in the last trading session.
Does ILLUMINA INC pay dividends?
ILMN does not pay a dividend.
What is the ChartMill technical and fundamental rating of ILMN stock?
ILMN has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What do analysts say about ILLUMINA INC (ILMN) stock?
27 analysts have analysed ILMN and the average price target is 132.25 USD. This implies a price decrease of -6.64% is expected in the next year compared to the current price of 141.65.
What sector and industry does ILLUMINA INC belong to?
ILLUMINA INC (ILMN) operates in the Health Care sector and the Life Sciences Tools & Services industry.